Glucose metabolism in CKD patients is affected by increased insulin resistance, impaired counter-regulatory hormone response (cortisol, growth hormone), malnutrition, and variability in exposure to oral hypoglycemic agents and exogenous insulin. This evidence concerns the gene GH1 and malnutrition.